Although only 5–10% of ovarian cancers are directly attributable to a germline mutation in BRCA1 or 2, there is a growing body of evidence to suggest that additional mechanisms of BRCA dysfunction are involved in the pathogenesis of ovarian cancer (26, 38, 39). Here, BRCA1 is linked to ovarian cancer.